Institute For Therapeutic Discovery Inc

Organization Overview

Institute For Therapeutic Discovery Inc is located in Providence, RI. The organization was established in 2004. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Therapeutic Discovery Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 06/2021, Institute For Therapeutic Discovery Inc generated $43.4k in total revenue. This represents relatively stable growth, over the past 5 years the organization has increased revenue by an average of 9.6% each year. All expenses for the organization totaled $46.2k during the year ending 06/2021. While expenses have increased by 8.1% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

DISCOVERY AND EARLY-STAGE RESEARCH BUILT ON BRIDGING BIOPHYSICS AND BIOCHEMISTRY TO HELP PHYSICIANS TREAT DISEASE BY RESTORING NATURAL FUNCTION AT THE CELLULAR LEVEL

Describe the Organization's Program Activity:

Part 3 - Line 4a

WE HAD VERY LITTLE ACTIVITY AT THE INSTITUTE FOR CHRONIC TRAUMATIC BRAIN INJURY, LLC ICTBI WHICH IS A DISREGARDED ENTITY FOR TAX PURPOSES. THE COVID-19 PANDEMIC LIMITED OUR OUTREADH AND FACE-TO-FACE CONTACTS. OUR PURPOSE REMAINS TO SUPPORT PRODUCT DEVELOPERS OR COMPANIES WITH PROMISING PRODUCTS FOR LONG-TERM, CHRONIC TRAUMATIC BRAIN INJURY 1 TO COMPLETE THE RESEARCH NECESSARY TO OBTAIN AN IND FROM THE FDA TO ENGAGE IN HUMAN CLINICAL TRIALS AND 2 TO COMPLETE THEIR FIRST SUCH TRIAL. FINANCIAL SUPPORT FOR THESE ACTIVITIES WILL BE PROVIDED BY MAKING MISSION RELATED INVESTMENTS IN SUCH PROJECTS EITHER FOR SHARES OR ROYALTIES OR SIMILAR INTERESTS AND WILL NOT GENERALLY BE PROVIDED BY MAKING ONLY GRANTS. FOR MANY PROJECTS OR COMPANIES THE PURCHASE OF SHARES OR ROYALTY INTERESTS IS FINANCIALLY EQUIVALENT TO GRANT SUPPORT. WHILE WE DO NOT CLASSIFY SUCH MISSION RELATED INVESTMENTS AS GRANTS, THE READER SHOULD RECOGNIZE THAT IN THE YEAR ENDING 2020 WE MADE AN INVESTMENT OF 50,000 IN FURTHERANCE OF THIS PROGRAM.


OUR CONTINUING PROGRAM FOR THE DISCOVERY AND EARLY STAGE RESEARCH OF USEFUL MEDICINAL COMPOUNDS BY BRIDGING BIOPHYSICS AND BIOCHEMISTRY CONTINUES AS IT HAS SINCE OUR FOUNDING. THE GOAL OF THIS PROGRAM HAS BEEN TO HELP MEDICAL PRACTITIONERS TREAT DISEASE BY RESTORING NATURAL FUNCTION AT THE CELLULAR LEVEL WITH A FOCUS ON CHRONIC CNS DISORDERS. THE PRACTITIONER GROUP CONTINUES TO MEET AS IT HAS SINCE THE FOUNDING OF THE INSTITUTE. OUR ROYALTY REVENUE ARISES FROM THIS WORK.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Dr Kara Fitzgerald
Director
$0
Dr Lloyd Saberski
Director
$0
Dr Betty Sadaniantz
Director
$0
Dr John Mcmichael
Chief Exec Officer
$0

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$36,149
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$36,149
Total Program Service Revenue$0
Investment income $0
Tax Exempt Bond Proceeds $0
Royalties $7,225
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $43,374

Create an account to unlock the data you need.

or